1 gen 2014 anni - $100 million from Alexion Pharmaceuticals
Descrizione:
Alexion Pharmaceuticals paid Moderna $100 million for ten product options to develop rare disease treatments, including for Crigler-Najjar syndrome, using Moderna's mRNA therapeutics platform
Aggiunto al nastro di tempo:
Data: